SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Camilla S. Graham, Tracy Swan, A path to eradication of hepatitis C in low- and middle-income countries, Antiviral Research, 2015,

    CrossRef

  2. 2
    A. Cousien, V. C. Tran, S. Deuffic-Burban, M. Jauffret-Roustide, J.-S. Dhersin, Y. Yazdanpanah, Dynamic modelling of hepatitis C virus transmission among people who inject drugs: a methodological review, Journal of Viral Hepatitis, 2015, 22, 2
  3. 3
    Natasha K. Martin, Peter Vickerman, David Goldberg, Matthew Hickman, HCV treatment as prevention in prison: Key issues, Hepatology, 2015, 61, 1
  4. 4
    N. K. Martin, G. R. Foster, J. Vilar, S. Ryder, M. E. Cramp, F. Gordon, J. F. Dillon, N. Craine, H. Busse, A. Clements, S. J. Hutchinson, A. Ustianowski, M. Ramsay, D. J. Goldberg, W. Irving, V. Hope, D. De Angelis, M. Lyons, P. Vickerman, M. Hickman, HCV treatment rates and sustained viral response among people who inject drugs in seven UK sites: real world results and modelling of treatment impact, Journal of Viral Hepatitis, 2015, 22, 2
  5. 5
    Josep Quer, Josep Gregori, Francisco Rodríguez-Frias, Maria Buti, Antonio Madejon, Sofia Perez-del-Pulgar, Damir Garcia-Cehic, Rosario Casillas, Maria Blasi, Maria Homs, David Tabernero, Miguel Alvarez-Tejado, Jose Manuel Muñoz, Maria Cubero, Andrea Caballero, Jose Antonio delCampo, Esteban Domingo, Irene Belmonte, Leonardo Nieto, Sabela Lens, Paloma Muñoz-de-Rueda, Paloma Sanz-Cameno, Silvia Sauleda, Marta Bes, Jordi Gomez, Carlos Briones, Celia Perales, Julie Sheldon, Lluis Castells, Lluis Viladomiu, Javier Salmeron, Angela Ruiz-Extremera, Rosa Quiles-Pérez, Ricardo Moreno-Otero, Rosario López-Rodríguez, Helena Allende, Manuel Romero-Gómez, Jaume Guardia, Rafael Esteban, Javier Garcia-Samaniego, Xavier Forns, Juan Ignacio Esteban, Y.-W. Tang, High-Resolution Hepatitis C Virus Subtyping Using NS5B Deep Sequencing and Phylogeny, an Alternative to Current Methods, Journal of Clinical Microbiology, 2015, 53, 1, 219

    CrossRef

  6. 6
    Michael H. Levy, Sarah Larney, The ethics of hepatitis C “treatment as prevention” among prisoners, Hepatology, 2015, 61, 1
  7. 7
    Ann-Sofi Duberg, Sarah Blach, Karolin Falconer, Martin Kåberg, Homie Razavi, Soo Aleman, The future disease burden of hepatitis C virus infection in Sweden and the impact of different treatment strategies, Scandinavian Journal of Gastroenterology, 2015, 50, 2, 233

    CrossRef

  8. 8
    A. A. Artenie, D. Jutras-Aswad, É. Roy, G. Zang, J.-M. Bamvita, A. Lévesque, J. Bruneau, Visits to primary care physicians among persons who inject drugs at high risk of hepatitis C virus infection: room for improvement, Journal of Viral Hepatitis, 2015, 22, 2
  9. 9
    Roger Williams, Richard Aspinall, Mark Bellis, Ginette Camps-Walsh, Matthew Cramp, Anil Dhawan, James Ferguson, Dan Forton, Graham Foster, Sir Ian Gilmore, Matthew Hickman, Mark Hudson, Deirdre Kelly, Andrew Langford, Martin Lombard, Louise Longworth, Natasha Martin, Kieran Moriarty, Philip Newsome, John O'Grady, Rachel Pryke, Harry Rutter, Stephen Ryder, Nick Sheron, Tom Smith, Addressing liver disease in the UK: a blueprint for attaining excellence in health care and reducing premature mortality from lifestyle issues of excess consumption of alcohol, obesity, and viral hepatitis, The Lancet, 2014, 384, 9958, 1953

    CrossRef

  10. 10
    Bethany White, Annie Madden, Maria Prins, Margaret Hellard, Handan Wand, Gregory J. Dore, Kimberly Page, Lisa Maher, Assessing the feasibility of hepatitis C virus vaccine trials: Results from the Hepatitis C Incidence and Transmission Study-community (HITS-c) vaccine preparedness study, Vaccine, 2014, 32, 42, 5460

    CrossRef

  11. 11
    George V. Papatheodoridis, Emmanuel Tsochatzis, Svenja Hardtke, Heiner Wedemeyer, Barriers to care and treatment for patients with chronic viral hepatitis in Europe: a systematic review, Liver International, 2014, 34, 10
  12. 12
    Jason Grebely, Gregory J. Dore, Can hepatitis C virus infection be eradicated in people who inject drugs?, Antiviral Research, 2014, 104, 62

    CrossRef

  13. 13
    Francesco Negro, Curbing hepatitis C virus spread in Egypt, The Lancet Global Health, 2014, 2, 9, e495

    CrossRef

  14. 14
    Romulus Breban, Naglaa Arafa, Sandrine Leroy, Aya Mostafa, Iman Bakr, Laura Tondeur, Mohamed Abdel-Hamid, Wahid Doss, Gamal Esmat, Mostafa K Mohamed, Arnaud Fontanet, Effect of preventive and curative interventions on hepatitis C virus transmission in Egypt (ANRS 1211): a modelling study, The Lancet Global Health, 2014, 2, 9, e541

    CrossRef

  15. 15
    A. G. Suryaprasad, J. Z. White, F. Xu, B.-A. Eichler, J. Hamilton, A. Patel, S. B. Hamdounia, D. R. Church, K. Barton, C. Fisher, K. Macomber, M. Stanley, S. M. Guilfoyle, K. Sweet, S. Liu, K. Iqbal, R. Tohme, U. Sharapov, B. A. Kupronis, J. W. Ward, S. D. Holmberg, Emerging Epidemic of Hepatitis C Virus Infections Among Young Nonurban Persons Who Inject Drugs in the United States, 2006-2012, Clinical Infectious Diseases, 2014, 59, 10, 1411

    CrossRef

  16. 16
    Margaret Hellard, Joseph S. Doyle, Rachel Sacks-Davis, Alexander J. Thompson, Emma McBryde, Eradication of hepatitis C infection: The importance of targeting people who inject drugs, Hepatology, 2014, 59, 2
  17. 17
    Harriet L. Mills, Samuel Johnson, Matthew Hickman, Nick S. Jones, Caroline Colijn, Errors in reported degrees and respondent driven sampling: Implications for bias, Drug and Alcohol Dependence, 2014, 142, 120

    CrossRef

  18. 18
    Knut Boe Kielland, Ellen J. Amundsen, Olav Dalgard, HCV treatment uptake in people who have injected drugs — observations in a large cohort that received addiction treatment 1970–1984, Scandinavian Journal of Gastroenterology, 2014, 49, 12, 1465

    CrossRef

  19. 19
    John W. Ward, Hepatitis C virus: The 25-year journey from discovery to cure, Hepatology, 2014, 60, 5
  20. 20
    N. Panneer, E. Lontok, B. M. Branson, C.-G. Teo, C. Dan, M. Parker, J. D. Stekler, A. DeMaria, V. Miller, HIV and Hepatitis C Virus Infection in the United States: Whom and How to Test, Clinical Infectious Diseases, 2014, 59, 6, 875

    CrossRef

  21. 21
    Margaret E Hellard, Joseph S Doyle, Interferon-free hepatitis C treatment: one pill to fit all?, The Lancet, 2014, 383, 9916, 491

    CrossRef

  22. 22
    Natasha K. Martin, Angela Devine, Jeffrey W. Eaton, Alec Miners, Timothy B. Hallett, Graham R. Foster, Gregory J. Dore, Philippa J. Easterbrook, Rosa Legood, Peter Vickerman, Modeling the impact of early antiretroviral therapy for adults coinfected with HIV and hepatitis B or C in South Africa, AIDS, 2014, 28, S35

    CrossRef

  23. 23
    Hamish Innes, David Goldberg, Geoffrey Dusheiko, Peter Hayes, Peter R. Mills, John F. Dillon, Esther Aspinall, Stephen T. Barclay, Sharon J. Hutchinson, Patient-important benefits of clearing the hepatitis C virus through treatment: A simulation model, Journal of Hepatology, 2014, 60, 6, 1118

    CrossRef

  24. 24
    Brendan Jacka, Tanya Applegate, Mel Krajden, Andrea Olmstead, P. Richard Harrigan, Brandon D.L. Marshall, Kora DeBeck, M.-J. Milloy, Francois Lamoury, Oliver G. Pybus, Viviane D. Lima, Gkikas Magiorkinis, Vincent Montoya, Julio Montaner, Jeffrey Joy, Conan Woods, Sabina Dobrer, Gregory J. Dore, Art F.Y. Poon, Jason Grebely, Phylogenetic clustering of hepatitis C virus among people who inject drugs in Vancouver, Canada, Hepatology, 2014, 60, 5
  25. 25
    Jean-Marie Bamvita, Elise Roy, Geng Zang, Didier Jutras-Aswad, Andreea Adelina Artenie, Annie Levesque, Julie Bruneau, Portraying Persons Who Inject Drugs Recently Infected with Hepatitis C Accessing Antiviral Treatment: A Cluster Analysis, Hepatitis Research and Treatment, 2014, 2014, 1

    CrossRef

  26. 26
    Philip Bruggmann, Jason Grebely, Prevention, treatment and care of hepatitis C virus infection among people who inject drugs, International Journal of Drug Policy, 2014,

    CrossRef

  27. 27
    Margaret Hellard, David A Rolls, Rachel Sacks-Davis, Garry Robins, Philippa Pattison, Peter Higgs, Campbell Aitken, Emma McBryde, The impact of injecting networks on hepatitis C transmission and treatment in people who inject drugs, Hepatology, 2014, 60, 6
  28. 28
    John W. Ward, The Role of Public Health in an Era of All-Oral Therapy for Hepatitis C Infection, Current Hepatitis Reports, 2013, 12, 4, 220

    CrossRef

  29. 29
    Philip Bruggmann, Treatment as prevention: The breaking of taboos is required in the fight against hepatitis C among people who inject drugs, Hepatology, 2013, 58, 5